Arvinas, Inc. Files 8-K Report
Ticker: ARVN · Form: 8-K · Filed: Mar 11, 2025 · CIK: 1655759
| Field | Detail |
|---|---|
| Company | Arvinas, Inc. (ARVN) |
| Form Type | 8-K |
| Filed Date | Mar 11, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, filing, SEC
TL;DR
ARVINAS FILES 8-K - CHECK FOR UPDATES
AI Summary
On March 11, 2025, Arvinas, Inc. filed an 8-K report. The filing primarily concerns Regulation FD disclosures, other events, and financial statements and exhibits. No specific financial figures or material events were detailed in the provided excerpt.
Why It Matters
This 8-K filing indicates that Arvinas, Inc. is providing updates or disclosures to the SEC, which could contain material information for investors.
Risk Assessment
Risk Level: low — The provided excerpt is a standard 8-K filing notification and does not contain specific material events or financial data that would indicate a change in risk.
Key Players & Entities
- Arvinas, Inc. (company) — Registrant
- 0001655759-25-000057 (other) — Accession Number
- March 11, 2025 (date) — Date of Report
- New Haven, Connecticut (location) — Principal Executive Offices
FAQ
What specific event triggered this 8-K filing?
The filing indicates it is for Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits, but the specific triggering event is not detailed in this excerpt.
When was this 8-K report filed?
The report was filed on March 11, 2025.
What is Arvinas, Inc.'s principal executive office address?
Arvinas, Inc.'s principal executive offices are located at 5 Science Park, 395 Winchester Ave., New Haven, Connecticut 06511.
What is the Commission File Number for Arvinas, Inc.?
The Commission File Number for Arvinas, Inc. is 001-38672.
What is the SIC code for Arvinas, Inc.?
The Standard Industrial Classification (SIC) code for Arvinas, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 11, 2025 regarding ARVINAS, INC. (ARVN).